Total Payments
$18,896
2024 Payments
$2,356
Companies
52
Transactions
1,134
Medicare Patients
11,520
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$18,586 (98.4%)
Education$309.96 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,586 | 1,112 | 98.4% |
| Education | $309.96 | 22 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $4,369 | 317 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,327 | 150 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,088 | 103 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,116 | 62 | $0 (2024) |
| Mylan Specialty L.P. | $1,082 | 64 | $0 (2024) |
| United Therapeutics Corporation | $994.18 | 33 | $0 (2024) |
| GENZYME CORPORATION | $922.07 | 43 | $0 (2024) |
| Grifols USA, LLC | $616.57 | 30 | $0 (2023) |
| PFIZER INC. | $482.69 | 27 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $435.38 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,356 | 107 | GlaxoSmithKline, LLC. ($477.00) |
| 2023 | $2,180 | 113 | Regeneron Healthcare Solutions, Inc. ($310.43) |
| 2022 | $2,713 | 151 | Boehringer Ingelheim Pharmaceuticals, Inc. ($403.04) |
| 2021 | $2,429 | 151 | Boehringer Ingelheim Pharmaceuticals, Inc. ($424.06) |
| 2020 | $1,886 | 120 | GlaxoSmithKline, LLC. ($649.53) |
| 2019 | $2,205 | 160 | GlaxoSmithKline, LLC. ($600.42) |
| 2018 | $2,598 | 177 | GlaxoSmithKline, LLC. ($955.40) |
| 2017 | $2,530 | 155 | GlaxoSmithKline, LLC. ($635.53) |
All Payment Transactions
1,134 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.57 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 11/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $26.02 | General |
| Category: Narcoplepsy | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology | ||||||
| 10/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.67 | General |
| 10/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $32.87 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 2,847 | 3,766 | $1.0M | $322,910 |
| 2022 | 14 | 3,120 | 4,138 | $956,149 | $341,067 |
| 2021 | 13 | 2,783 | 3,552 | $766,256 | $328,789 |
| 2020 | 15 | 2,770 | 3,785 | $833,216 | $296,008 |
Total Patients
11,520
Total Services
15,241
Medicare Billing
$1.3M
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,002 | 1,612 | $378,920 | $151,060 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 647 | 775 | $136,110 | $50,240 | 36.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 72 | 73 | $118,844 | $36,532 | 30.7% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 572 | 731 | $109,650 | $20,871 | 19.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 121 | 121 | $47,840 | $18,783 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 122 | 122 | $39,690 | $13,841 | 34.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 112 | 116 | $127,600 | $13,141 | 10.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 18 | 18 | $26,460 | $8,615 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 33 | $9,120 | $4,390 | 48.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $12,920 | $3,861 | 29.9% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 11 | 11 | $12,100 | $729.50 | 6.0% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 32 | 36 | $4,320 | $328.79 | 7.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 30 | 35 | $9,275 | $274.21 | 3.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 31 | 36 | $6,192 | $244.47 | 3.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 1,025 | 1,544 | $290,000 | $147,331 | 50.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 791 | 982 | $140,360 | $65,065 | 46.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 59 | 60 | $97,680 | $30,503 | 31.2% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 670 | 960 | $144,000 | $28,222 | 19.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 148 | 148 | $56,240 | $24,264 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 129 | 129 | $38,700 | $15,616 | 40.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 96 | 97 | $106,700 | $12,432 | 11.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 55 | $12,100 | $7,192 | 59.4% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 14 | 14 | $20,580 | $6,508 | 31.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 23 | 23 | $25,300 | $1,640 | 6.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $4,000 | $1,371 | 34.3% |
About Dr. Guy Foster, MD
Dr. Guy Foster, MD is a Pulmonary Disease healthcare provider based in Carson City, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871674861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guy Foster, MD has received a total of $18,896 in payments from pharmaceutical and medical device companies, with $2,356 received in 2024. These payments were reported across 1,134 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($18,586).
As a Medicare-enrolled provider, Foster has provided services to 11,520 Medicare beneficiaries, totaling 15,241 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Carson City, NV
- Active Since 10/18/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1871674861
Products in Payments
- DUPIXENT (Biological) $2,068
- TRELEGY ELLIPTA (Drug) $1,565
- NUCALA (Biological) $1,390
- OFEV (Drug) $1,183
- ORENITRAM (Drug) $833.76
- ANORO (Drug) $596.68
- BREO (Drug) $593.74
- STIOLTO RESPIMAT (Drug) $505.12
- Yupelri (Drug) $484.00
- BREZTRI (Drug) $473.02
- YUPELRI (Drug) $462.64
- Prolastin-C Liquid (Biological) $445.16
- SPIRIVA RESPIMAT (Drug) $401.66
- BEVESPI AEROSPHERE (Drug) $398.25
- GLASSIA (Biological) $329.22
- SYMBICORT (Drug) $328.18
- Arikayce (Drug) $306.75
- ELIQUIS (Drug) $294.78
- Hillrom - Life 2000 Ventilation System (Device) $273.53
- ACTHAR (Biological) $250.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.